In men with an initial PSA level between 3 and 20 ng/mL, the PSA density demonstrated a superior diagnostic accuracy compared to the PSA, PSA change, or absolute PSA change for predicting prostate cancer and csPCa. This evidence concerns the gene KLK3 and prostate cancer.